Lanean...
CRISPR and transposon in vivo screens for cancer drivers and therapeutic targets
Human cancers harbor substantial genetic, epigenetic, and transcriptional changes, only some of which drive oncogenesis at certain times during cancer evolution. Identifying the cancer-driver alterations amongst the vast swathes of “passenger” changes still remains a major challenge. Transposon and...
Gorde:
| Argitaratua izan da: | Genome Biol |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7437018/ https://ncbi.nlm.nih.gov/pubmed/32811551 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13059-020-02118-9 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|